Ekso Bionics Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurements (Details) - USD ($) $ in Thousands	Sep. 30, 2017	Dec. 31, 2016
Liabilities:
Warrant liabilities	$ 767	$ 3,546
Contingent success fee liability	13
Fair Value, Measurements, Recurring [Member]
Liabilities:
Warrant liabilities	767	3,546
Contingent consideration liability	248	217
Contingent success fee liability	13	116
Quoted Prices in Active Markets for Identical Items Level 1 [Member] \| Fair Value, Measurements, Recurring [Member]
Liabilities:
Warrant liabilities	0	0
Contingent consideration liability	0	0
Contingent success fee liability	0	0
Significant Other Observable Inputs Level 2 [Member] \| Fair Value, Measurements, Recurring [Member]
Liabilities:
Warrant liabilities	0	0
Contingent consideration liability	0	0
Contingent success fee liability	0	0
Significant Unobservable Inputs Level 3 [Member] \| Fair Value, Measurements, Recurring [Member]
Liabilities:
Warrant liabilities	767	3,546
Contingent consideration liability	248	217
Contingent success fee liability	$ 13	$ 116